Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Benha University
This study will be carried out on two groups:
• Group (I): fifty children diagnosed to have duchenne muscular dystrophy and inflammatory myositis.
Group (II): including 20 healthy children matching age and sex as control group.
patients will be subjected to
(A) Clinical evaluation
1. Complete history taking.
2. Thorough clinical examination.
3. Body mass index (BMI) assessment.
4. Quantitative muscle strength tests
5. Functional grading
6. Childhood Myositis Assessment Scale. 7 (B) Laboratory assessment:
All patients will be subjected to the following measurements:
1. Serum creatine kinase levels (CK).
2. Serum Lactate dehydrogenase levels
3. Serum of Liver enzymes (SGOT\& SGPT) levels.
(C) Electromyographic (EMG) assessment:
(D) Musculoskeletal ultrasound assessment (E) Statistical analysis
Age
2–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
children with Duchenne muscular dystrophy (DMD). Diagnosis with DMD was established according to DMD diagnostic criteria (Jennekens et al., 1991).
children with juvenile dermatomyositis (JDM) according to Bohan and Peter diagnostic criteria ( (Bohan and Peter, 1975).
You may not be if
Patients with age less than 2 years were excluded from the study due to inability to perform manual muscle testing and functional scales.
If no final diagnosis could be established.
The presence of a concomitant illness that may result in peripheral neuropathy or myopathy.